ELAVL1 and glaucoma: According to our previous (Smedowski et al., 2018) and present evidence, we may infer that HuR loss within RGCs is a general feature of glaucomatous damage and that factors (i.e., genetic variability and drugs) blocking or decreasing HuR function/expression at the retinal level likely contribute to accelerating glaucoma induced RGC loss and dysfunction.